{"id":"W3199488937","doi":"10.17863/cam.66211","title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.","year":2021,"lang":"en","type":"article","venue":"Edinburgh Research Explorer (University of Edinburgh)","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"NIHR Cambridge Biomedical Research Centre; NIHR Imperial Biomedical Research Centre; NIHR Newcastle Biomedical Research Centre; Public Health England; Dr. Falk Pharma; National Institute for Health and Care Research; Genentech; Royal Devon and Exeter NHS Foundation Trust; Galápagos; Vifor Pharma; Crohn's and Colitis UK; Public Health Wales; Leona M. and Harry B. Helmsley Charitable Trust; Celgene; Pfizer; Biogen; Sanofi; F. Hoffmann-La Roche; Celltrion; Roche; Amgen; IC Design Education Center; Celltrion Healthcare; Allergan; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Infliximab; Medicine; Vedolizumab; Internal medicine; Seroconversion; Concomitant; Gastroenterology; Serology; Immunology; Vaccination; Antibody; Ulcerative colitis; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004164095,0.0002504646,0.0003386379,0.0003415411,0.0002661295,0.0004894655,0.0001683696,0.0005125126,0.002234999],"category_scores_gemma":[0.001985265,0.0002141098,0.0003188025,0.0004093428,0.0002035052,0.0003914663,0.000219801,0.0004258531,0.0003385112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001918163,"about_ca_system_score_gemma":0.0001228304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008807854,"about_ca_topic_score_gemma":0.001257502,"domain_scores_codex":[0.9995424,0.0001426435,0.00005648652,0.0001090873,0.00006978701,0.00007960962],"domain_scores_gemma":[0.9989709,0.0002043577,0.0005907751,0.00003666935,0.0000530648,0.0001442727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00048592,0.0000455907,0.9967085,0.00001648766,0.00004457981,0.0001280472,0.00007081977,0.00002274409,0.0006803001,0.000006123025,0.00005914127,0.001731702],"study_design_scores_gemma":[0.00001985469,0.0002923717,0.9988906,0.000005115989,0.00002283185,0.0004870265,0.00005051357,0.000062608,0.00005954661,0.000005000824,0.0001031676,0.000001396845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994838,0.0002616133,0.00002755525,0.00002884729,0.000003965279,0.00000259144,0.00004400096,0.000001797859,0.0001457308],"genre_scores_gemma":[0.9997653,0.00005319601,0.00002480038,0.00002272813,0.000007245928,0.000002146344,0.0000606693,5.011831e-7,0.00006340608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002234999,"threshold_uncertainty_score":0.007476807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08125932260396923,"score_gpt":0.3493702546509735,"score_spread":0.2681109320470043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}